What FDA and EU GMP Annex 15 actually require, how acceptance limits are calculated, and why cleaning verification is not the same as cleaning validation.
Cleaning validation sits at the intersection of two regulatory expectations that are frequently confused in practice: demonstrating that a cleaning procedure works, and proving it works consistently enough to rely on without re-verifying every time. This course works through FDA's cleaning validation expectations under 21 CFR 211.67 and EU GMP Annex 15, the statistical and scientific basis for setting acceptance limits, worst-case product and equipment grouping, swab and rinse sampling methodology, and the specific documentation an inspector expects to see in a cleaning validation protocol and report.
Cleaning validation failures are a recurring theme in FDA 483 observations, most often because a firm can demonstrate a cleaning procedure was followed but cannot demonstrate, with data, that it consistently achieves an acceptable residue limit. Since the shift toward health-based exposure limits, firms that have not updated legacy acceptance criteria are increasingly exposed at inspection. This course is built directly from the current regulatory text and FDA enforcement pattern, not a secondary summary.
Completion certificate, PDF slide download, and access to the complete GMP course library from day one.
Start this course →